Abu Dhabi withdraws these six medicines

Wednesday, 6 November 2019 19:25

Batches of six different medicines have been pulled off the shelves in Abu Dhabi for failing to meet official specifications.

They include Amydramine paediatric syrup, Moxal Plus tablet, Julphamox 500 mg capsule, Julmentin 2X tablet, Rosuvastatin and Oxaliplatin.

These drugs are prescribed for the treatment of allergies, colon cancer, respiratory tract infections and lowering cholesterol.

The Department of Health (DoH) Abu Dhabi has asked pharmacies and hospitals to return their stock to the supplier.

More from UAE

UAE offers condolences following Saudi helicopter crash

The United Arab Emirates has expressed its solidarity with Saudi Arabia and the victims of the crash of a helicopter on Sunday belonging to Saudi Aramco in the Ras Tanura region, which resulted in the death of all its passengers.
First genomics-driven UAE clinical trial targets Alzheimer's risk

The UAE has launched its first genomics-driven clinical trial, using data from the Emirati Genome Programme to identify people at risk of Alzheimer's disease before symptoms develop, in a major milestone for precision and preventive healthcare.
Reem Al Hashimy honoured with top Italian leadership award

Reem bint Ebrahim Al Hashimy, UAE Minister of State for International Cooperation, has been awarded the Marisa Bellisario Award, one of Italy’s leading honours recognising outstanding women in leadership.
UAE condemns Iranian attacks on Bahrain and Kuwait

The United Arab Emirates has condemned renewed Iranian hostile attacks targeting Bahrain and Kuwait with missiles and drones.